NEW YORK (

TheStreet

) -- The ex-dividend date for

Teva Pharmaceutical Industries

(Nasdaq:

TEVA

) is tomorrow, February 23, 2012. Owners of shares as of market close today will be eligible for a dividend of 20 cents per share. At a price of $44.61 as of 9:30 a.m. ET, the dividend yield is 1.7%.

The average volume for Teva has been 5.4 million shares per day over the past 30 days. Teva has a market cap of $43.16 billion and is part of the

health care

sector and

drugs

industry. Shares are up 12.1% year to date as of the close of trading on Tuesday.

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, produces, and markets generic drugs; and proprietary branded pharmaceuticals in various therapeutic categories and active pharmaceutical ingredients worldwide. The company has a P/E ratio of 9.5, below the average drugs industry P/E ratio of 13.7 and below the S&P 500 P/E ratio of 17.7.

  • Sign up for TheStreet's FREE Dividend and Income Investor Newsletter

TheStreet Ratings rates Teva as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels, good cash flow from operations, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. You can view the full

Teva Ratings Report

.

See our

dividend calendar

or

top-yielding stocks list

.

null